The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
Abstract
Activated protein C (APC) resistance caused by the factor V Leiden mutation is associated with an increased risk of venous thrombosis. We investigated whether a reduced response to APC, not due to the factor V point mutation, is also a risk factor for venous thrombosis. For this analysis, we used the Leiden Thrombophilia Study (LETS), a case-control study for venous thrombosis including 474 patients with a first deep-vein thrombosis and 474 age- and sex-matched controls. All carriers of the factor V Leiden mutation were excluded. A dose-response relationship was observed between the sensitivity for APC and the risk of thrombosis: the lower the normalized APC sensitivity ratio, the higher the associated risk. The risk for the lowest quartile of normalized APC-SR (<0.92), which included 16.5% of the healthy controls, compared with the highest quartile (normalized APC-SR > 1.05) was greater than fourfold increased (OR = 4.4; 95% confidence interval, 2.9 to 6.6). We adjusted for VIII:C levels, which appeared to affect our APC resistance test. The adjusted (age, sex, FVIII:C) odds ratio for the lowest quartile was 2.5 (95% confidence interval, 1.5 to 4.2). So, after adjustment for factor VIII levels, a reduced response to APC remained a risk factor. Our results show that a reduced sensitivity for APC, not caused by the factor V Leiden mutation, is a risk factor for venous thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Self-citationON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Dahlbäck, B., Carlsson, M., & Svensson, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1004 · Cited by 1,945
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationKoster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
Self-citationResistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlback, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,102
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Self-citationKoster, T., Rosendaal, F., Briet, E., van der Meer, F., Colly, L., Trienekens, P., Poort, Sr., Reitsma, P., & Vandenbroucke, J. (1995) · Blood · doi:10.1182/blood.v85.10.2756.bloodjournal85102756 · Cited by 364
Self-citationvan Hinsbergh, V., Bertina, R., van Wijngaarden, A., van Tilburg, N., Emeis, J., & Haverkate, F. (1985) · Blood · doi:10.1182/blood.v65.2.444.444 · Cited by 302
Self-citationKoster, T., Rosendaal, F. R., Reitsma, P. H., Velden, P. A. V. D., Briët, E., & Vandenbroucke, J. P. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642511 · Cited by 293
Self-citationFactor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
Williamson, D., Brown, K., Luddington, R., Baglin, C., & Baglin, T. (1998) · Blood · doi:10.1182/blood.v91.4.1140 · Cited by 288
Nicolaes, G. A. F., Tans, G., Thomassen, M. C. L. G. D., Hemker, H. C., Pabinger, I., Varadi, K., Schwarz, H. P., & Rosing, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21158 · Cited by 229
Characterization of the Molecular Defect in Factor VR506A
Kalafatis, M., Bertina, R. M., Rand, M. D., & Mann, K. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.4053 · Cited by 216
Self-citationA Novel Mutation of Arg306 of Factor V Gene in Hong Kong Chinese
Chan, W. P., Lee, C. K., Kwong, Y. L., Lam, C. K., & Liang, R. (1998) · Blood · doi:10.1182/blood.v91.4.1135 · Cited by 216
Development of resistance to activated protein C during pregnancy
CUMMING, A. M., TAIT, R. C., FILDES, S., YOONG, A., KEENEY, S., & HAY, C. R. M. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05610.x · Cited by 197
de Ronde, H., & Bertina, R. M. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648978 · Cited by 186
Self-citationResistance to activated protein C in healthy women taking oral contraceptives
Olivieri, O., Friso, S., Manzato, F., Guella, A., Bernardi, F., Lunghi, B., Girelli, D., Azzini, M., Brocco, G., Russo, C. A., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05323.x · Cited by 129
van der Bom, J. G., Bots, M. L., Haverkate, F., Slagboom, P. E., Meijer, P., de Jong, P. T. V. M., Albert Hofman, D., Grobbee, D. E., & Kluft, C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00002 · Cited by 128
Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V
Heeb, M., Kojima, Y., Greengard, J. S., & Griffin, J. H. (1995) · Blood · doi:10.1182/blood.v85.12.3405.bloodjournal85123405 · Cited by 120
An update on clinical and basic aspects of the protein C anticoagulant pathway
Esmon, C. T. (1995) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00054-d · Cited by 105
Fisher, M., Fernández, J. A., Ameriso, S. F., Xie, D., Gruber, A., Paganini‐Hill, A., & Griffin, J. H. (1996) · Stroke · doi:10.1161/01.str.27.7.1163 · Cited by 76
Bloemenkamp, K. W. M., Helmerhorst, F. M., Koster, T., Bertina, R. M., Vandenbroucke, J. P., & Rosendaal, F. R. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615216 · Cited by 64
Self-citationAPARICIO, C., & Dahlbäck, B. (1996) · Biochemical Journal · doi:10.1042/bj3130467 · Cited by 47
Roelse, J., Koopman, M. M. W., Buller, H. R., ten Cate, J. W., Montaruli, B., van MOURIK, J. A., & Voorberg, J. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.349885.x · Cited by 23
Legnani, C., Palareti, G., Biagi, R., COCCHERI, S., Bernardi, F., Rosendaal, F. R., Reitsma, P. H., de Ronde, H., & Bertina, R. M. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1709.x · Cited by 15
Self-citation
Cited by
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Self-citationRole of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Kujovich, J. L. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3181faa0f2 · Cited by 419
Metadata
- Authors
- de Visser, M. C. H., Rosendaal, F. R., & Bertina, R. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1999-02-15
- Volume
- 93
- Issue
- 4
- Pages
- 1271-1276
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2117767595
- Cited by
- 308
- References
- 26
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.